Victoria Ronan is an Assistant Professor in the Department of Pediatrics at the Medical College of Wisconsin, specializing in Critical Care. She holds board certifications in General Pediatrics and Critical Care Medicine. Her research focuses on the gut microbiome's role in neurocritical illness, pediatric critical care, and neurodevelopmental outcomes. Ronan completed her MBBS at the University of Limerick and postgraduate training in Pediatrics and Critical Care at institutions including Sinai Hospital of Baltimore and the University of Chicago. She has authored studies on microbiome dynamics in childhood development and Alzheimer’s-related antibody therapies. Key honors include the Bright Futures Scholar and First Class Honors in Pediatrics. She leads grants such as the 'Gut Microbiome in Neurocritical Illness' and serves on committees including the Pediatric Neurocritical Care Research Group’s Outcomes Group and DEI Subcommittee. Education: B.S. in Biomedical Science (University of South Florida), MBBS (University of Limerick). Training: Pediatric Critical Care Fellowship at University of Chicago Comer Children’s Hospital. Her research interests span microbiome alterations in critical illness, neurocritical care interventions, and translational medicine. Ronan has contributed to over 15 peer-reviewed articles, emphasizing microbiome-gut-brain interactions and anti-amyloid therapies. She actively participates in clinical trials like PRECISE and the Pediatric ICECAPS study.
Bridget E. Young, Ph.D., is an Associate Professor at the University of Rochester School of Medicine and Dentistry, holding joint appointments in the Department of Pediatrics and Department of Public Health Sciences. As Director of Research for the Division of Breastfeeding and Lactation Medicine, she leads clinical studies investigating how bioactive components in human milk influence infant development. Research Focus: Maternal obesity, insulin resistance, and their impacts on breast milk composition; neonatal pancreatic function and intestinal maturation; donor milk processing; infant microbiome dynamics Laboratory: Young Lab at Golisano Children's Hospital, specializing in bioactive milk analysis and infant health outcomes Research Trends: Her recent publications analyze milk composition variability, microbiome differences between feeding methods, and immunological impacts of maternal conditions on breast milk. Articles from 2022-2025 particularly emphasize SARS-CoV-2 antibody transfer through milk and nutritional disparities in commercial infant formulas. Scientific Recognition: Erlich Koldovsky Early Career Award (2021) NIH F32 Award recipient Thrasher Research Fund Early Investigator Award Multiple grants for lactation research Collaborative Network: Works with international researchers through the BEGIN Consortium and co-founded the University of Rochester Human Milk and Lactation Research Consortium. Her lab team includes certified lactation counselors supporting breastfeeding mothers in clinical studies.
Luiz Roesch is an Associate Professor in the Department of Microbiology and Cell Science at the University of Florida. His research focuses on microbial diversity, metagenomics, and the interplay between microbiomes and human/animal health. He has contributed to understanding microbial communities in environments ranging from soil and gut ecosystems to space missions. His work bridges microbiology with clinical, environmental, and agricultural applications. Education details are not explicitly provided in the text, but his research spans over 20 years with publications since 2014. His studies include genomic characterization of bacteria, microbial responses to environmental changes, and associations between microbiota and diseases like osteoporosis, glycogen storage disorders, and sepsis. Key research interests include bacterial species diversity, antibiotic resistance in neonates, microbiome-genotype interactions, and microbial contributions to human pathologies. Recent articles highlight innovations in sequencing pipelines (e.g., RESCUE) and applications of microbiome data to clinical and agricultural contexts. His articles collectively address themes like microbial resilience under environmental stress, human microbiome-disease links, and agricultural sustainability. No awards are mentioned, but his work reflects significant contributions to microbial research methodologies and interdisciplinary applications. Lab affiliations or grant details are not specified, though his position suggests involvement in university research infrastructure. His office is located in Room 1247 of the Microbiology Building (#981) on the UF campus.
Kerstin Skovgaard is a Senior Researcher at the Department of Biotechnology and Biomedicine , Technical University of Denmark . Her work focuses on antiviral immunology with emphasis on zoonotic influenza viruses and metabolic syndrome's impact on infection severity . She develops translational animal models for innate immune research in respiratory infections and post-traumatic conditions . Research Interests Antiviral Immunology of influenza A viruses and PEDV Metabolic Syndrome and obesity-related immunity Translational models for respiratory diseases and gut-brain axis miRNA profiling in equine osteoarthritis and porcine infections Immunomodulatory diets with algae and probiotics Biomarker discovery through proteomics and RT-qPCR Scientific Contributions include 202+ publications across influenza , gut immunity , and joint inflammation . Her recent 15 articles demonstrate expertise in porcine models for human diseases , with emphasis on innate immune responses , miRNA dynamics , and metabolic-immune interactions . Supervision includes PhD students : J. Pina Agullet B. L. Henriksen C. J. M. Polhaus H. A. Laybourn C. López-Figueroa Methodologies encompass microfluidic qPCR , RNA-Seq , and advanced in vitro systems . Her research supports UN Sustainable Development Goals through cost-efficient diagnostics and therapeutic development .
Mustafa Berber serves as an Assistant Professor in the Department of Child Health and Pediatrics at Yeditepe University Faculty of Medicine, Istanbul. His academic appointment commenced in 2015, and he maintains active clinical and research responsibilities within the university's medical education framework. Education: MD, Istanbul University Faculty of Medicine (2000) Specialization in Child Health and Diseases, Marmara University Faculty of Medicine (2005) - Thesis: Factors predicting drug-resistant epilepsy in children Subspecialty in Neonatology, Yeditepe University Faculty of Medicine (2011) - Thesis: Etanercept and melatonin effects on fetal brain cytokines in intrauterine inflammation rat models Research Focus: Dr. Berber's work spans neonatal neurology (epilepsy, convulsions), growth physiology (IGF axis, socioeconomic impacts), and pediatric immunology (anaphylaxis management, vaccination). His research consistently examines how socioeconomic factors influence child health outcomes, particularly in Turkish populations. The growth disorders domain features prominently through studies on IGF parameters and anthropometric standards. Publication Trends: His 8 peer-reviewed articles (2005-2014) reveal a clinical-translational trajectory from basic growth physiology (2005-2007) toward complex pathophysiological investigations (2011-2014). Key methodological threads include population-specific reference ranges , socioeconomic health determinants , and neonatal neurocritical care , with increasing emphasis on molecular pathways in later work. Academic Contributions: Dr. Berber has consistently taught 14 undergraduate medical courses annually since 2015, specializing in neonatal neurology ( neonatal convulsions, neurodegenerative disorders ) and preventive care ( immunization principles, infection approaches ). His thesis supervision extends to master's-level research, though specific student names remain unlisted in available records. External clinical experience includes service at Rize Education and Research Hospital (2012).
John Baines holds the position of Professor in Evolutionary Genomics at Kiel University (Christian-Albrechts-Universität zu Kiel) and is a Principal Investigator at the Max Planck Institute for Evolutionary Biology in Plön, Germany. Additionally, he holds an SH Excellence Chair, serves as the speaker of the Clinician Scientist Program in Evolutionary Medicine, and coordinates the Evolutionary Medicine function area within the master's program Medical Life Science at Kiel University. His laboratory is based at the Institute for Experimental Medicine (IEM) located in Kiel, where he leads research on the interplay between host evolution and microbiome dynamics. Professor Baines' research program centers on Evolutionary Genomics and Host-Microbiome Interactions, with a particular emphasis on understanding bacterial evolution in the context of chronic inflammatory diseases. His work investigates how host-microbiome metabolic interactions change with aging and disease, using mouse models to study inflammatory bowel disease, anorexia nervosa, and other conditions. He integrates genomic, metagenomic, and computational approaches to dissect the mechanisms by which host genetics and environmental factors shape the microbiome and influence disease progression and treatment outcomes. Analysis of his publication record from 2016 to 2025 shows a consistent and growing body of work in microbiome research, particularly focused on gut microbiota in health and disease. His studies frequently address the evolutionary aspects of host-microbiome co-adaptation, the impact of host genetic variation (such as in NOD2 and vitamin D receptor genes) on microbiome composition, and the clinical implications of microbiome dynamics in diverse patient populations. This research spans multiple disciplines including genomics, immunology, and computational biology, reflecting a highly interdisciplinary approach. Based on the provided information, no specific scientific awards, prizes, or fellowships are attributed to Professor Baines. However, his research is supported by competitive funding from the Deutsche Forschungsgemeinschaft (DFG), indicating recognition of his work by the scientific community. Professor Baines actively mentors students and researchers through his role in the Clinician Scientist Program and as coordinator of the Evolutionary Medicine component in the Medical Life Science master's program. His research group receives funding from the DFG for projects investigating bacterial evolution during chronic inflammation and the potential for restorative therapies based on ancestral bacterial states. These grants support a range of activities from basic research to translational applications. The Baines laboratory, part of the Evolutionary Medicine group at the Institute for Experimental Medicine, Kiel University, collaborates extensively with the Max Planck Institute for Evolutionary Biology and other institutions including the Research Center Borstel and the University Medical Center Schleswig-Holstein. Current projects, such as the investigation of bacterial evolution in inflammatory bowel disease (Phases 1 and 2 of project P10), aim to translate evolutionary insights into novel therapeutic strategies for restoring healthy microbiome states.
Patricia Denning is an Adjunct Professor at the Institute for Biomedical Sciences, Georgia State University, and an Assistant Professor in neonatal-perinatal medicine at Emory University. Her research focuses on understanding the developmental regulation of intestinal innate immunity and its role in necrotizing enterocolitis (NEC) in premature infants. Her educational background includes: M.D. from Baylor College of Medicine (1991-1995) Pediatric Residency at Baylor College of Medicine (1995-1997) and Boston University Medical School (1997-1998) Clinical Neonatology Fellowship and GI Research Fellowship at Harvard Medical School (1998-2002) Dr. Denning's research centers on how immature intestinal host defenses predispose premature infants to NEC. She investigates bacterial-host interactions and the role of normal bacterial colonization in maturing intestinal innate immune responses. Her work has significant implications for developing preventive strategies against NEC, a leading cause of neonatal morbidity and mortality. Analysis of her recent publications reveals a strong focus on the interplay between gut microbiota (particularly probiotics like Lactobacillus) and intestinal immunity in neonates. Key themes include the mechanisms by which commensal bacteria and probiotics enhance host defenses, prevent NEC, and regulate inflammatory and apoptotic pathways in the developing gut. Her research spans molecular, cellular, and clinical aspects of neonatal gastrointestinal diseases. While specific laboratory or team details are not provided in the text, her extensive publication record in high-impact journals indicates an active research program investigating the developmental biology of gut immunity and NEC pathogenesis.
Professor Valerie Verhasselt, MD, PhD, is Director of the Larsson-Rosenquist Centre for Immunology and Breastfeeding at the University of Western Australia (UWA) and the Telethon Kids Institute (TKI). With over 20 years of translational research experience, her work focuses on breastfeeding's impact on immune development and child health, revolutionizing allergy prevention through a landmark Nature Medicine 2008 study. UWA Medical School Telethon Kids Institute Research Highlights: Landmark malaria prevention via breast milk antigen transfer Lead investigator in 1000-child birth cohort studies Co-author of European Academy of Allergy guidelines Grants & Collaborations: Larsson Rosenquist Foundation (ongoing) Open Philanthropy's $12M Fuel for Survival project (2025-2029) Channel 7 Telethon Trust & WA Department of Health funding Scientific Recognition: 2012 Prix de l'Academie Nationale de Medecine 2008 Prix de l'Academie des Sciences Academic Contributions: Coordinates UWA's "Breastfeeding - A Foundation for Human Health" course Over 80 publications in top journals ( Nature Medicine , JAMA Pediatrics , Lancet Infectious Disease ) 40+ invited lectures in past 3 years
Sasirekha Ramani is an Assistant Professor in the Department of Molecular Virology and Microbiology at Baylor College of Medicine , Houston, TX. Her research focuses on viral gastroenteritis caused by rotaviruses and noroviruses, emphasizing maternal and child health, immune responses to infections and vaccines, and the role of glycans in infectious diseases. She leads the Ramani Lab, which combines molecular virology, epidemiology, and clinical studies to address disease susceptibility and vaccine efficacy. Her work integrates human intestinal organoid cultures with field studies, providing insights into human-pathogen interactions. Key collaborations span clinical, epidemiological, and virology research, with a focus on resource-limited settings. The lab’s long-term goals include developing interventions against enteric pathogens and understanding microbiome influences on infections. Recent publications highlight advancements in norovirus cultivation in enteroids, rotavirus glycan interactions, and translational research on vaccines and antivirals. Dr. Ramani’s interdisciplinary approach bridges basic science and clinical applications, aiming to improve global public health outcomes in enteric diseases.
Dr. Lynn Mahony is Professor of Pediatrics at UT Southwestern Medical Center, where she chairs the NHLBI-funded Pediatric Heart Network. Her clinical expertise spans pediatric cardiology with research focus on congenital heart disease outcomes and clinical trials. Key research areas include: Long-term outcomes of Fontan procedure Neurodevelopmental sequelae of congenital heart disease Marfan syndrome therapeutics Quality of life assessment methodologies Perioperative management protocols She leads multicenter clinical trials investigating pharmacological interventions for Marfan syndrome and single ventricle physiology. Recent publications emphasize functional outcomes, quality of life metrics, and neurodevelopmental trajectories in pediatric cardiac populations. Dr. Mahony mentors early-career investigators through the Pediatric Heart Network and contributes to guideline development for congenital heart disease management.
Dr. Rosangela Mezghanni is an Associate Professor in the Department of Pediatrics at the University of Maryland School of Medicine . Her research focuses on human translational immunology , particularly the interplay between innate and adaptive immune responses to enteric pathogens like Salmonella , E. coli , and Shigella . She pioneered a patented 3-D organotypic model of human intestinal mucosa to replace animal models in studying mucosal immunity. Education : PhD in Microbiology & Immunology from Paris Descartes University; DEA in Microbiology; B.Sc. in Medical Analysis. Research Themes : Epigenetic regulation during pathogen infections MAIT cell and T follicular helper cell interactions Vaccine-induced immune signatures (Ty21a, tularemia) Secretory IgA-microbiota dynamics in preterm infants HLA-E restricted CD8+ T cell mechanisms Key Publications (2019–2025) reveal expertise in: Salmonella pathogenesis Vaccine correlates of protection Organoid-based mucosal studies Microgravity-enabled immunology Epigenetic immune programming Awards & Patents : Co-inventor of US Patent 9,200,258 for 3-D intestinal model Collaborations span institutions including University of Maryland, University of Paris, and NIH-funded projects.
Dr. Veronica Ayechu Muruzabal is a Researcher at the Faculty of Science , Utrecht University , focusing on Department of Pharmaceutical Sciences and Pharmacology . Her work centers on early-life immune development, prebiotics, and postbiotics' role in modulating immunity. Research Themes: The first 1001 days in a child's life, life sciences Research Interests: Immunology and nutrition in infant health Human milk oligosaccharides (HMOs) and their impact on mucosal immunity Dietary interventions for allergic inflammation Galectin signaling in immune cell interactions Epigenetic modifications in food allergy prevention Prebiotics and postbiotics in immune system education Notable Article Trends: Her publications from 2017-2022 highlight HMOs (e.g., 2′-fucosyllactose) and microbial metabolites in enhancing regulatory immunity, suppressing allergies, and modifying galectin activity. Key collaborative journals include Journal of Innate Immunity , Frontiers in Pediatrics , and International Journal of Molecular Sciences . Collaborations: Work includes co-authors like Garssen, Van’t Land, and Stahl—affiliated with Utrecht University's Life Sciences and pharmaceutical sciences divisions.
Prof. Dr. Andrew Macpherson is a leading academic at the University of Bern , serving as Head of Research Group at the Department of Biomedical Research (DBMR) and Director of Gastroenterology at Inselspital. His work bridges Multidisciplinary Center for Infectious Diseases (MCID) and One Health initiatives. Dr. Macpherson's research focuses on: Microbiota-Host Interactions Gut Immunology (Th17 cell differentiation, B cell repertoire shaping) Intestinal Epithelial Stress (ER stress, ROS signaling) Recent publications in Nature , Science , and Immunity analyze microbial fitness, sentinel cell technologies, and cross-organ system microbiota effects. His team received multiple scientific awards : Per Brandtzaeg Distinguished Achievement Award SGG Gastroenterology Research Award Johanna Dürmüller-Bol DBMR Award Mentorship highlights include advising Ziad Al Nabhani (ERC grant) and Stephanie Ganal-Vonarburg (Peter Hans Hofschneider Professorship). The lab employs sterile mouse models and transcriptional recording technologies to study microbiota dynamics and therapeutic interventions like fecal transplantation .
Kirsten Pilegaard is a Senior Adviser at the National Food Institute , Technical University of Denmark. With a scientific background in toxicology and quantitative pathology , she specializes in evaluating the toxic effects of bioactive constituents in plants and mushrooms, particularly within food supplements, novel foods, and botanical ingredients. Key affiliations: Technical University of Denmark (2007–present), Danish Institute for Food and Veterinary Research (2004–2006), Institute of Toxicology, National Food Agency (1988–2003) Primary research areas: Natural toxins , botanical safety , and risk-benefit assessments for food products. Her work includes participation in EFSA working groups (2007–present) and contributions to the Drogeliste , a database evaluating food supplement safety. She has collaborated on projects like EUROFIR , focusing on bioactive plant compounds, and studied endocrine disruptors in mammary gland development. Notable contributions include advising national food authorities, supervising PhD students Anne-Sofie R. Ballegaard and K. M. Egebjerg , and authoring 62 publications, including peer-reviewed articles on quinoa allergenicity and linseed health impacts. Recent media engagements include commentaries on food supplement risks (ashwagandha, DMAA, green tea) and public appearances addressing peanut allergy burdens and quinoa's safety for infant diets.
Amanda Ramer-Tait is the Maxcy Professor of Agriculture and Natural Resources in the Department of Food Science and Technology at the University of Nebraska-Lincoln. Her research focuses on the complex interactions between diet, gut microbiome, and host health, particularly in the context of inflammation, metabolic diseases, and immune modulation. Current affiliations: University of Nebraska-Lincoln Key research areas: Gut microbiome dynamics, dietary biochemistry, microbial-immune crosstalk Her recent work examines how dietary components (e.g., blueberries, sorghum, polyphenols) influence gut microbiota composition and function, impacting conditions like colitis, obesity, and cardiovascular disease. Studies also explore bacterial engraftment, host susceptibility to infections, and microbiome-based therapies for allergies and cancer. Scientific trends in her publications emphasize microbial ecology, diet-microbiome interactions, and translational models (germ-free, humanized mice). Key subfields include polyphenol metabolism, intestinal permeability, immune tolerance, and pathobiont dynamics.
